Composition of the Nomination Committee of Orion Corporation

Composition of the Nomination Committee of Orion Corporation

ID: 68352

(Thomson Reuters ONE) -


ORION CORPORATION STOCK EXCHANGE RELEASE 21 September 2011 at 18.27  EEST

The Board of Directors of Orion Corporation has elected the following persons to
the Nomination Committee of the company:

Kari Jussi Aho
Matti Kavetvuo
Timo Ritakallio
Seppo Salonen
Hannu Syrjänen
Jukka Ylppö

Matti Kavetvuo was elected Chairman of the Committee.

The Committee prepares and presents a recommendation to the Board of Directors
for the proposal to the Annual General Meeting concerning the composition of the
Board. The term of the Nomination Committee shall end at the closing of the next
Annual General Meeting of the company.

The essentials of the working order of the Nomination Committee and a
description of the election process of its members are provided
athttp://www.orion.fi/board-committees, a page in the Corporate Governance
section of the Orion Group internet website.



Orion Corporation


Timo Lappalainen Olli Huotari
President and CEO SVP, Corporate Functions



Contact person:

Timo Lappalainen, President and CEO, phone +358 10 426 3692


Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo
www.orion.fi

Orion is an innovative European R&D-based pharmaceutical and diagnostic company
with a special emphasis on developing medicinal treatments and diagnostic tests
for global markets. Orion develops, manufactures and markets human and
veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic
tests. Orion's pharmaceutical R&D focuses on the following core therapy areas:
central nervous system drugs, cancer and critical care drugs, and Easyhaler®
pulmonary drugs.

The Group's net sales in 2010 amounted to EUR 850 million. The Company invested
EUR 85 million in research and development. At the end of 2010, the Group had a




total of approximately 3,100 employees, of whom 2,450 worked in Finland and 650
in other countries. Orion's A and B shares are listed on NASDAQ OMX Helsinki.









This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Orion Oyj via Thomson Reuters ONE

[HUG#1548568]


Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Confirmed Net Asset Value(s) SHARE REPURCHASE 21.9.2011
Bereitgestellt von Benutzer: hugin
Datum: 21.09.2011 - 17:28 Uhr
Sprache: Deutsch
News-ID 68352
Anzahl Zeichen: 2866

contact information:
Town:

Espoo



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 152 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Composition of the Nomination Committee of Orion Corporation"
steht unter der journalistisch-redaktionellen Verantwortung von

Orion Oyj (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Orion Oyj



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z